Protective effect of an ERAP1 haplotype in ankylosing spondylitis: Investigating non-MHC genes in HLA-B27-positive individuals

Rheumatology (United Kingdom)

Volumn 52, Issue 12, 2013, Pages 2168-2176

  Bettencourt, Bruno Filipe ^a,b   Rocha, Fabiana Leal ^a,b   Alves, Helena ^c   Amorim, Rosa ^d   Caetano Lopes, Joana ^e   Vieira Sousa, Elsa ^e,f   Pimentel Santos, Fernando ^g,h   Lima, Manuela ^b,i   Porto, Graça ^b,j   Branco, Jaime C ^g,h   Fonseca, João Eurico ^e,f   Bruges Armas, Jácome ^a,b  

^a SEEBMO Hospital de Santo Espirito da Ilha Terceira Azores   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c Ministerio da Saude Portuguese   (Portugal)

^d Hospital Distrital das Caldas da Rainha   (Portugal)

^e UNIVERSITY OF LISBON   (Portugal)

^f HOSPITAL DE SANTA MARIA   (Portugal)

^g NOVA MEDICAL SCHOOL   (Portugal)

^h HOSPITAL EGAS MONIZ   (Portugal)

ⁱ UNIVERSITY OF THE AZORES   (Portugal)

^j UNIVERSITY OF PORTO   (Portugal)

more..

Author keywords

Ankylosing spondylitis; ERAP1; IL23R; Protection haplotype; TNFSF15

Indexed keywords

AMINOPEPTIDASE; BIOLOGICAL MARKER; ENDOPLASMIC RETICULUM AMINOPEPTIDASE 1; HLA B27 ANTIGEN; INTERLEUKIN 23 RECEPTOR; PEPTIDE HYDROLASE; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL GROWTH INHIBITOR;

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; CELL PROTECTION; FEMALE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ANKYLOSING SPONDYLITIS; ERAP1; IL23R; PROTECTION HAPLOTYPE; TNFSF15;

ADULT; AGED; AMINOPEPTIDASES; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HLA-B27 ANTIGEN; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, INTERLEUKIN; SPONDYLITIS, ANKYLOSING; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 15;

EID: 84887669101     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ket269     Document Type: Article

References (39)

1. Brown MA, Pile KD, Kennedy LG et al. HLA class I associations of ankylosing spondylitis in the white population in the United Kingdom. Ann Rheum Dis 1996;55:268-70.
2. Brown MA, Kennedy LG, MacGregor AJ et al. Susceptibility to ankylosing spondylitis in twins:the role of genes, HLA, and the environment. Arthritis Rheum 1997;40:1823-8.
3. Consortium WTCCC/TASC. Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet 2007;39:1329-37.
4. Laval SH, Timms A, Edwards S et al. Whole-genome screening in ankylosing spondylitis:evidence of non-MHC genetic-susceptibility loci. Am J Hum Genet 2001;68:918-26.
5. Consortium TASC. Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci. Nat Genet 2010;42:123-7.
6. Consortium TASC/WTCCC2. Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nat Genet 2011;43:761-7.
7. Saric T, Chang SC, Hattori A et al. An IFN-gamma-induced aminopeptidase in the ER, ERAP1, trims precursors to MHC class I-presented peptides. Nat Immunol 2002;3:1169-76.
8. Saveanu L, Carroll O, Lindo V et al. Concerted peptide trimming by human ERAP1 and ERAP2 aminopeptidase complexes in the endoplasmic reticulum. Nat Immunol 2005;6:689-97.
9. Cui X, Rouhani FN, Hawari F et al. Shedding of the type II IL-1 decoy receptor requires a multifunctional aminopeptidase, aminopeptidase regulator of TNF receptor type 1 shedding. J Immunol 2003;171:6814-9.
10. Parham C, Chirica M, Timans J et al. A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R. J Immunol 2002;168:5699-708.
11. Cua DJ, Sherlock J, Chen Y et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 2003;421:744-8.
12. Murphy CA, Langrish CL, Chen Y et al. Divergent pro- and anti-inflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J Exp Med 2003;198:1951-7.
13. Zinovieva E, Bourgain C, Kadi A et al. Comprehensive linkage and association analyses identify haplotype, near to the TNFSF15 gene, significantly associated with spondyloarthritis. PLoS Genet 2009;5:e1000528.
14. Jandus C, Bioley G, Rivals JP et al. Increased numbers of circulating polyfunctional Th17 memory cells in patients with seronegative spondylarthritides. Arthritis Rheum 2008;58:2307-17.
15. van der Linden SM, Valkenburg HA, de Jongh BM et al. The risk of developing ankylosing spondylitis in HLA-B27 positive individuals. A comparison of relatives of spondylitis patients with the general population. Arthritis Rheum 1984;27:241-9.
16. van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984;27:361-8.
17. Pimentel-Santos FM, Ligeiro D, Matos M et al. Association of IL23R and ERAP1 genes with ankylosing spondylitis in a Portuguese population. Clin Exp Rheumatol 2009;27:800-6.
18. Purcell S, Neale B, Todd-Brown K et al. PLINK:a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007;81:559-75.
19. Wigginton JE, Cutler DJ, Abecasis GR. A note on exact tests of Hardy-Weinberg equilibrium. Am J Hum Genet 2005;76:887-93.
20. Li Y, Willer C, Sanna S et al. Genotype imputation. Annu Rev Genomics Hum Genet 2009;10:387-406.
21. Li Y, Willer CJ, Ding J et al. MaCH:using sequence and genotype data to estimate haplotypes and unobserved genotypes. Genet Epidemiol 2010;34:816-34.
22. Pruim RJ, Welch RP, Sanna S et al. LocusZoom:regional visualization of genome-wide association scan results. Bioinformatics 2010;26:2336-7.
23. Barrett JC, Fry B, Maller J et al. Haploview:analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21:263-5.
24. Gabriel SB, Schaffner SF, Nguyen H et al. The structure of haplotype blocks in the human genome. Science 2002;296:2225-9.
25. Purcell S, Cherny SS, Sham PC. Genetic Power Calculator:design of linkage and association genetic mapping studies of complex traits. Bioinformatics 2003;19:149-50.
26. Choi CB, Kim TH, Jun JB et al. ARTS1 polymorphisms are associated with ankylosing spondylitis in Koreans. Ann Rheum Dis 2010;69:582-4.
27. Davidson SI, Wu X, Liu Y et al. Association of ERAP1, but not IL23R, with ankylosing spondylitis in a Han Chinese population. Arthritis Rheum 2009;60:3263-8.
28. Maksymowych WP, Inman RD, Gladman DD et al. Association of a specific ERAP1/ARTS1 haplotype with disease susceptibility in ankylosing spondylitis. Arthritis Rheum 2009;60:1317-23.
29. Rueda B, Orozco G, Raya E et al. The IL23R Arg381Gln non-synonymous polymorphism confers susceptibility to ankylosing spondylitis. Ann Rheum Dis 2008;67:1451-4.
30. Safrany E, Pazar B, Csongei V et al. Variants of the IL23R gene are associated with ankylosing spondylitis but not with Sjogren syndrome in Hungarian population samples. Scand J Immunol 2009;70:68-74.
31. Tsui FW, Haroon N, Reveille JD et al. Association of an ERAP1 ERAP2 haplotype with familial ankylosing spondylitis. Ann Rheum Dis 2010;69:733-6.
32. Harvey D, Pointon JJ, Evans DM et al. Investigating the genetic association between ERAP1 and ankylosing spondylitis. Hum Mol Genet 2009;18:4204-12.
33. Szczypiorska M, Sanchez A, Bartolome N et al. ERAP1 polymorphisms and haplotypes are associated with ankylosing spondylitis susceptibility and functional severity in a Spanish population. Rheumatology 2011;50:1969-75.
34. Pazar B, Safrany E, Gergely P et al. Association of ARTS1 gene polymorphisms with ankylosing spondylitis in the Hungarian population:the rs27044 variant is associated with HLA-B*2705 subtype in Hungarian patients with ankylosing spondylitis. J Rheumatol 2010;37:379-84.
35. Nguyen TT, Chang SC, Evnouchidou I et al. Structural basis for antigenic peptide precursor processing by the endoplasmic reticulum aminopeptidase ERAP1. Nat Struct Mol Biol 2011;18:604-13.
36. Kochan G, Krojer T, Harvey D et al. Crystal structures of the endoplasmic reticulum aminopeptidase-1 (ERAP1) reveal the molecular basis for N-terminal peptide trimming. Proc Natl Acad Sci USA 2011;108:7745-50.
37. Garcia-Medel N, Sanz-Bravo A, Van Nguyen D et al. Functional interaction of the ankylosing spondylitisassociated endoplasmic reticulum aminopeptidase 1 polymorphism and HLA-B27 in vivo. Mol Cell Proteomics 2012;11:1416-29.
38. York IA, Chang SC, Saric T et al. The ER aminopeptidase ERAP1 enhances or limits antigen presentation by trimming epitopes to 8-9 residues. Nat Immunol 2002;3:1177-84.
39. Bettencourt BF, Foroni I, Couto AR et al. In:Bruges- Armas J, ed., Genetics in ankylosing spondylitis-beyond HLA-B*27. Clinical and molecular advances in ankylosing spondylitis. http://www.intechopen.com/jobs-at-intech. html:InTech, 2012:105-34.